Similar articles

• Increasing influenza vaccination coverage in recommended population groups in Europe.

  Blank PR, Szucs TD. Blank PR, et al. Expert Rev Vaccines. 2009 Apr;8(4):425-33. doi: 10.1586/erv.09.7. Expert Rev Vaccines. 2009. PMID: 19348558 Review.
• Influenza vaccination coverage rates in 5 European countries: a population-based cross-sectional analysis of the seasons 02/03, 03/04 and 04/05.

  Müller D, Szucs TD. Müller D, et al. Infection. 2007 Oct;35(5):308-19. doi: 10.1007/s15010-007-6218-5. Epub 2007 Sep 20. Infection. 2007. PMID: 17885730
• Influenza vaccine 2011-2012.

  [No authors listed] [No authors listed] Med Lett Drugs Ther. 2011 Oct 17;53(1375):81-3. Med Lett Drugs Ther. 2011. PMID: 21996921 Review. No abstract available.
• CCVID patients may not respond to influenza immunization.

  Sewell WA. Sewell WA. Clin Immunol. 2005 Feb;114(2):210; author reply 211. doi: 10.1016/j.clim.2004.10.004. Clin Immunol. 2005. PMID: 15639655 No abstract available.
• New vaccine approaches for seasonal and pandemic influenza.

  Palache B. Palache B. Vaccine. 2008 Nov 18;26(49):6232-6. doi: 10.1016/j.vaccine.2008.07.022. Epub 2008 Jul 30. Vaccine. 2008. PMID: 18674583 Review.